277 citations,
June 2003 in “The journal of investigative dermatology. Symposium proceedings/The Journal of investigative dermatology symposium proceedings”
Epithelial-mesenchymal interactions control hair growth cycles through specific molecular signals.
A 27-year-old shares his 7-year journey using finasteride and 4 years with minoxidil to combat hairloss, experiencing cycles of shedding and regrowth. Despite emotional challenges, he finds the treatments worthwhile, though he still faces insecurities and uncertainties about shedding phases.
The conversation is about long-term finasteride use for hairloss, with users discussing periods of improvement and worsening, and considering switching to dutasteride. Other treatments mentioned include minoxidil, red light therapy, microneedling, and scalp massaging.
Increased scalp itching during shedding phases while on finasteride treatment may coincide with hair regrowth and recovery. This suggests that itching might not always indicate continued hairloss and could encourage persistence with the treatment.
Some people claim Dutasteride worsened their hairloss, causing concern among users. Reasons suggested include initial shedding phases, incorrect attribution to Dutasteride when other factors are involved, genetic variations affecting drug response, and the possibility of non-authentic medication.
The conversation is about the progress and development of a hairloss treatment called GT20029. People are discussing updates on its status and speculating on how long it will take to become available.